Tiffany Wilson

Tiffany Wilson has spent more than two decades translating scientific and technological innovation into real-world impact across medical devices, healthcare technology, and advanced industries. She is widely recognized for her leadership at the intersection of commercialization, ecosystem building, and institutional change.

In October 2020, Tiffany was appointed President and CEO of the University City Science Center, where she has led a multi-year transformation of the organization into a venture-aligned innovation intermediary focused on turning discovery into outcomes—new companies, deployed technologies, quality jobs, and improved health. Under her leadership, the Science Center has shifted from a traditional real-estate-anchored model to a platform that convenes founders, health systems, industry, investors, and government around evidence-driven commercialization, capital readiness, and adoption at scale.

Prior to joining the Science Center, Tiffany was CEO of the Global Center for Medical Innovation (GCMI) in Atlanta, which she helped launch and operationalize beginning in 2011. At GCMI, she built a nationally recognized, capital-efficient model for advancing medical device innovation from concept through testing, regulatory submission, and market entry by aligning infrastructure, expertise, and risk-reduction pathways for early-stage companies. Her contributions to strengthening the medical device ecosystem were recognized by both Georgia Bio and Southeast Life Sciences.

Earlier in her career, Tiffany held senior leadership roles at Scientific Intake and ACell, a regenerative medicine company acquired by Integra LifeSciences, where she led corporate strategy, finance, business development, regulatory affairs, and reimbursement initiatives. She began her career in management consulting and investment banking, developing deep expertise in strategy, market analysis, and transaction execution.

Tiffany currently serves on multiple civic, industry, and innovation advisory boards and is a frequent speaker on innovation commercialization, ecosystem strategy, and leadership in complex systems. Her work has been recognized by the Philadelphia Business Journal Power 100, The Healthcare Technology Report, Inc. Magazine, and Becker’s Hospital Review, among others.

She holds an MBA from the Georgetown University McDonough School of Business and a BBA in International Business from Loyola University New Orleans.